S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
NYSE:CANO

Cano Health (CANO) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$2.00
$9.31
52-Week Range
N/A
Volume
159,142 shs
Average Volume
423,785 shs
Market Capitalization
$12.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.85

Cano Health MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
∞ Upside
$1.85 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.10mentions of Cano Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$1.43 M Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($2.01) to ($29.82) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.68 out of 5 stars

Medical Sector

862nd out of 939 stocks

Offices & Clinics Of Medical Doctors Industry

6th out of 7 stocks

CANO stock logo

About Cano Health Stock (NYSE:CANO)

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

CANO Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
American League East Preview Capsules
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Firm Retention Summary: Cano Health
Cano Health Secures $150M in Crucial Financing Deal
Cano Health's fall from grace
Cano Health Receives NYSE Delisting Notice Post-Bankruptcy
Cano Health Strikes Restructuring Deal Amid Bankruptcy
Cano Health files bankruptcy to restructure its debt
Why Is Cano Health (CANO) Stock Down 51% Today?
See More Headlines
Receive CANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cano Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Fax
N/A
Employees
4,365
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.85
High Stock Price Target
$3.75
Low Stock Price Target
$0.80
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-207,270,000.00
Pretax Margin
-36.27%

Debt

Sales & Book Value

Annual Sales
$2.74 billion
Book Value
$100.28 per share

Miscellaneous

Free Float
4,653,000
Market Cap
$12.39 million
Optionable
Optionable
Beta
0.05
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

CANO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cano Health stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CANO shares.
View CANO analyst ratings
or view top-rated stocks.

What is Cano Health's stock price target for 2024?

3 brokerages have issued 12-month price objectives for Cano Health's stock. Their CANO share price targets range from $0.80 to $3.75. On average, they anticipate the company's stock price to reach $1.85 in the next twelve months.
View analysts price targets for CANO
or view top-rated stocks among Wall Street analysts.

Who are Cano Health's major shareholders?

Cano Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.42%), Cutler Group LLC CA (0.00%), GTS Securities LLC (0.00%), Wolverine Trading LLC (0.00%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Brian D Koppy, David J Armstrong, Elliot Cooperstone, Lewis Gold, Marlow Hernandez, Richard Aguilar, Robert Camerlinck and Solomon D Trujillo.
View institutional ownership trends
.

How do I buy shares of Cano Health?

Shares of CANO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CANO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners